Skip to main content
Clinical Trials/JPRN-UMIN000028756
JPRN-UMIN000028756
Completed
未知

An exploratory clinical study on the safety of combination therapy with effector cell therapy and immune checkpoint inhibitors. - An exploratory clinical study on the safety of combination therapy with effector cell therapy and immune checkpoint inhibitors.

KOUSHIKAI,Non-profitmedicalcorporation0 sites10 target enrollmentAugust 22, 2017
ConditionsMalignant tumor

Overview

Phase
未知
Intervention
Not specified
Conditions
Malignant tumor
Sponsor
KOUSHIKAI,Non-profitmedicalcorporation
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 22, 2017
End Date
March 14, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
KOUSHIKAI,Non-profitmedicalcorporation

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • A patient MUST NOT: (1\)Have treated with immune checkpoint inhibitors. (2\)Be a female who is pregnant, lactating, or with a possibility of pregnancy. (3\)Be determined to be inappropriate by the doctor in charge.

Outcomes

Primary Outcomes

Not specified

Similar Trials